These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16429324)

  • 1. Etiologic factors in Paget's disease of bone.
    Reddy SV
    Cell Mol Life Sci; 2006 Feb; 63(4):391-8. PubMed ID: 16429324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiology of Paget's disease and osteoclast abnormalities.
    Reddy SV
    J Cell Biochem; 2004 Nov; 93(4):688-96. PubMed ID: 15389972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
    Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
    J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paget's disease: epidemiology and pathophysiology.
    Seton M
    Curr Osteoporos Rep; 2008 Dec; 6(4):125-9. PubMed ID: 19032921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paget's disease and osteoclast biology.
    Roodman GD
    Bone; 1996 Sep; 19(3):209-12. PubMed ID: 8873960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of Paget's disease of bone.
    Ralston SH
    Bone; 2008 Nov; 43(5):819-25. PubMed ID: 18672105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone.
    Yip KH; Feng H; Pavlos NJ; Zheng MH; Xu J
    Am J Pathol; 2006 Aug; 169(2):503-14. PubMed ID: 16877352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease.
    Kurihara N; Hiruma Y; Yamana K; Michou L; Rousseau C; Morissette J; Galson DL; Teramachi J; Zhou H; Dempster DW; Windle JJ; Brown JP; Roodman GD
    Cell Metab; 2011 Jan; 13(1):23-34. PubMed ID: 21195346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p62 mutations, ubiquitin recognition and Paget's disease of bone.
    Layfield R; Cavey JR; Najat D; Long J; Sheppard PW; Ralston SH; Searle MS
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):735-7. PubMed ID: 17052185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone.
    Rea SL; Walsh JP; Layfield R; Ratajczak T; Xu J
    Endocr Rev; 2013 Aug; 34(4):501-24. PubMed ID: 23612225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of Paget's disease of bone.
    Michou L; Collet C; Laplanche JL; Orcel P; Cornélis F
    Joint Bone Spine; 2006 May; 73(3):243-8. PubMed ID: 16574459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the pathogenesis of Paget's disease.
    Roodman GD
    Ann N Y Acad Sci; 2010 Mar; 1192():176-80. PubMed ID: 20392234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p62/sequestosome 1 deficiency accelerates osteoclastogenesis
    Zach F; Polzer F; Mueller A; Gessner A
    J Biol Chem; 2018 Jun; 293(24):9530-9541. PubMed ID: 29555685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin-associated domain mutations of SQSTM1 in Paget's disease of bone: evidence for a founder effect in patients of British descent.
    Lucas GJ; Hocking LJ; Daroszewska A; Cundy T; Nicholson GC; Walsh JP; Fraser WD; Meier C; Hooper MJ; Ralston SH
    J Bone Miner Res; 2005 Feb; 20(2):227-31. PubMed ID: 15647816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multinucleated cells formed in vitro from Paget's bone marrow express viral antigens.
    Mills BG; Frausto A; Singer FR; Ohsaki Y; Demulder A; Roodman GD
    Bone; 1994; 15(4):443-8. PubMed ID: 7917585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease.
    Friedrichs WE; Reddy SV; Bruder JM; Cundy T; Cornish J; Singer FR; Roodman GD
    J Bone Miner Res; 2002 Jan; 17(1):145-51. PubMed ID: 11771661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequences.
    Hocking LJ; Lucas GJ; Daroszewska A; Cundy T; Nicholson GC; Donath J; Walsh JP; Finlayson C; Cavey JR; Ciani B; Sheppard PW; Searle MS; Layfield R; Ralston SH
    J Bone Miner Res; 2004 Jul; 19(7):1122-7. PubMed ID: 15176995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice.
    Daroszewska A; van 't Hof RJ; Rojas JA; Layfield R; Landao-Basonga E; Rose L; Rose K; Ralston SH
    Hum Mol Genet; 2011 Jul; 20(14):2734-44. PubMed ID: 21515589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed development of Paget's disease in offspring inheriting SQSTM1 mutations.
    Bolland MJ; Tong PC; Naot D; Callon KE; Wattie DJ; Gamble GD; Cundy T
    J Bone Miner Res; 2007 Mar; 22(3):411-5. PubMed ID: 17181397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.
    Hiruma Y; Kurihara N; Subler MA; Zhou H; Boykin CS; Zhang H; Ishizuka S; Dempster DW; Roodman GD; Windle JJ
    Hum Mol Genet; 2008 Dec; 17(23):3708-19. PubMed ID: 18765443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.